Fundraising FoxImmatics
4 known investors
Find your way into Immatics
Sign up to see every warm intro you have to Immatics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immatics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MIG portfolio company taken public.
Founders & leadership
HS
Harpreet SinghFounder · Board Member (Executive Director)Harpreet Singh is Co-Founder and Chief Executive Officer of Immatics, a publicly traded biotechnology company focused on T-cell immunotherapy and PRAME-targeted treatments for advanced solid cancers. He holds a PhD in immunology from the University of Tuebingen.
Investors · 4
EMBL Ventureslisted by EMBL VenturesHeidelberg · $108K – $5.4M
How we know: EMBL Ventures's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Grazia Equity GmbHlisted by Grazia Equity GmbHStuttgart · $540K – $2.7M
How we know: Grazia Equity GmbH's portfolio page · Not right? Tell us
Related companies · 4
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
NasdaqNasdaq operates a technology infrastructure platform for financial markets across three business segments: Capital Access Platforms (which includes listing services, indices, and analytics tools), Financial Technology (comprising compliance, regulatory, and capital markets software), and Market Services (equities and derivatives trading operations). The company serves financial institutions, listed companies, investment managers, and regulatory agencies globally.
Simply Wall StSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.
ImvaxImvax is a clinical-stage biopharmaceutical company developing personalized immunotherapies aimed at treating solid tumors, including glioblastoma. Its platform draws on autologous, cell-based approaches to target cancer.
Companies working in the same space as Immatics.
In the news
Frequently asked questions
- What does Immatics do?
- MIG portfolio company taken public.
- Who founded Immatics?
- Immatics was founded by Harpreet Singh.
- Who are Immatics's investors?
- Immatics's investors include EMBL Ventures, Grazia Equity GmbH, LSG Holdings, MIG Capital AG.